Hexarelin Acetate

Hexarelin acts primarily through growth hormone secretagogue receptor pathways, including GHSR-1a, also known as the ghrelin receptor. In endocrine research, activation of this receptor is associated with growth hormone release through pituitary and hypothalamic signalling mechanisms.

Research involving Hexarelin Acetate focuses on growth hormone secretagogue activity, ghrelin receptor signalling, pituitary response, and neuroendocrine regulation. Additional studies have examined direct cardiovascular and metabolic effects that may involve CD36-related pathways, separate from its growth hormone-releasing activity.

Common research areas include:

• GHSR-1a / ghrelin receptor signalling
• Growth hormone secretagogue activity
• Pituitary and hypothalamic response models
• Neuroendocrine regulation studies
• Cardiac and metabolic pathway research involving CD36-related mechanisms